Clicky

Alexandria Real Estate Equities, Inc.(ARE)

Description: Alexandria Real Estate Equities, Inc., a real estate investment trust (REIT), engages in the ownership, operation, management, development, acquisition, and redevelopment of properties for the life sciences industry. Its properties consist of buildings containing scientific research and development laboratories, and other improvements. The company offers its properties for lease primarily to universities and independent not-for-profit institutions; and pharmaceutical, biotechnology, medical device, life science product, service, biodefense, and translational research entities, as well as governmental agencies. As of December 31, 2006, it had 159 properties, including 156 properties located in 9 states in the United States and 3 properties located in Canada. As a REIT, the company is not subject to federal income tax to the extent that it distributes 100% of its taxable income to its stockholders. The company was founded in 1993 and is based in Pasadena, California.


Keywords: Biotechnology Real Estate Investment Trust S&P 500 Biodefense Real Estate Equities

Home Page: www.are.com

ARE Technical Analysis

26 North Euclid Avenue
Pasadena, CA 91101
United States
Phone: 626-578-0777


Officers

Name Title
Mr. Joel S. Marcus CPA, J.D. Founder & Exec. Chairman
Mr. Peter M. Moglia CEO & Co-Chief Investment Officer
Mr. Dean A. Shigenaga CPA Pres & CFO
Mr. Daniel J. Ryan Co-Chief Investment Officer & Regional Market Director of San Diego
Mr. John H. Cunningham Exec. VP & Regional Market Director of New York City
Mr. Hunter L. Kass Exec. VP & Regional Market Director at Greater Boston
Mr. Lawrence J. Diamond Co-COO & Regional Market Director of Maryland
Mr. Joseph Hakman Co-COO & Chief Strategic Transactions Officer
Mr. Andres R. Gavinet CPA, CPA Chief Accounting Officer
Dr. Monica Rivera Beam Ph.D. Sr. VP of Science & Technology

Exchange: NYSE

Country: US

Currency: US Dollar ($)

Forward PE: 17.2414
Trailing PE: 44.1265
Price-to-Book MRQ: 1.4248
Price-to-Sales TTM: 9.8744
IPO Date: 1997-05-27
Fiscal Year End: December
Full Time Employees: 559
Back to stocks